Direct repression of cyclin D1 by SIP1 attenuates cell cycle progression in cells undergoing an epithelial mesenchymal transition.
about
The ZEB/miR-200 feedback loop--a motor of cellular plasticity in development and cancer?Tumour progression and metastasisEpithelial-mesenchymal plasticity in carcinoma metastasisAlpha-enolase as a potential cancer prognostic marker promotes cell growth, migration, and invasion in gliomaSnail promotes CXCR2 ligand-dependent tumor progression in non-small cell lung carcinomaMesenchymal gene program-expressing ovarian cancer spheroids exhibit enhanced mesothelial clearancePrognostic significance of ZEB1 and ZEB2 in digestive cancers: a cohort-based analysis and secondary analysis.Oncogenic features of neuromedin U in breast cancer are associated with NMUR2 expression involving crosstalk with members of the WNT signaling pathway.Regulation of glioblastoma progression by cord blood stem cells is mediated by downregulation of cyclin D1.SIP1 is downregulated in hepatocellular carcinoma by promoter hypermethylationTSC2 epigenetic defect in primary LAM cells. Evidence of an anchorage-independent survival.Remodeling of purinergic receptor-mediated Ca2+ signaling as a consequence of EGF-induced epithelial-mesenchymal transition in breast cancer cellsRepetitive antigen stimulation induces stepwise transcriptome diversification but preserves a core signature of memory CD8(+) T cell differentiation.The anterior gradient 2 (AGR2) gene is overexpressed in prostate cancer and may be useful as a urine sediment marker for prostate cancer detection.Association of invasion-promoting tenascin-C additional domains with breast cancers in young women.Overexpression of ZEB2 in peritumoral liver tissue correlates with favorable survival after curative resection of hepatocellular carcinoma.Bioinformatic approaches to augment study of epithelial-to-mesenchymal transition in lung cancerA signature of epithelial-mesenchymal plasticity and stromal activation in primary tumor modulates late recurrence in breast cancer independent of disease subtype.ZEB2 mediates multiple pathways regulating cell proliferation, migration, invasion, and apoptosis in glioma.Multilayer control of the EMT master regulators.Mechanism of the Ca²+-dependent interaction between S100A4 and tail fragments of nonmuscle myosin heavy chain IIA.Protein expression of ZEB2 in renal cell carcinoma and its prognostic significance in patient survivalNotch signaling and EMT in non-small cell lung cancer: biological significance and therapeutic application.Fra-1/AP-1 induces EMT in mammary epithelial cells by modulating Zeb1/2 and TGFβ expressionImplications of epithelial-mesenchymal plasticity for heterogeneity in colorectal cancer.FRA-1 as a driver of tumour heterogeneity: a nexus between oncogenes and embryonic signalling pathways in cancer.A switch from CD44⁺ cell to EMT cell drives the metastasis of prostate cancerParaquat induces epithelial-mesenchymal transition-like cellular response resulting in fibrogenesis and the prevention of apoptosis in human pulmonary epithelial cells.Small RNA sequencing reveals microRNAs that modulate angiotensin II effects in vascular smooth muscle cellsTranscriptional regulation of the cyclin D1 gene at a glance.The transcription factor Zeb2 regulates signaling in mast cellsMesenchymal Stromal Cells Epithelial Transition Induced by Renal Tubular Cells-Derived Extracellular VesiclesDifferent effects of ZO-1, ZO-2 and ZO-3 silencing on kidney collecting duct principal cell proliferation and adhesion.Valproate inhibits colon cancer growth through cell cycle modification in vivo and in vitroSIP1 is a downstream effector of GADD45G in senescence induction and growth inhibition of liver tumor cells.Cyclin-dependent kinase-mediated phosphorylation of breast cancer metastasis suppressor 1 (BRMS1) affects cell migration.A distinct role for interleukin-6 as a major mediator of cellular adjustment to an altered culture condition.Biodegradable interstitial release polymer loading a novel small molecule targeting Axl receptor tyrosine kinase and reducing brain tumour migration and invasion.Tumor cell dissemination: emerging biological insights from animal models and cancer patients.The embryonic transcription factor Brachyury blocks cell cycle progression and mediates tumor resistance to conventional antitumor therapies.
P2860
Q24617121-F64B4411-C47F-4F97-9D61-47C7D6F3E915Q26766468-4FBE1C91-F216-4A68-995E-398FB80FF4BEQ26859804-2AA70691-39EC-4694-BED6-0C33F6D9F5E9Q28236366-7B655B01-E0B5-4858-8474-C6C73ED6BA07Q30434154-59F7F230-1F8E-4077-AD49-B423DEA288C2Q30579225-5EAE90E2-4668-4CCF-94A4-F07EEE40F4FBQ33761782-D256C3A3-F36A-44F1-B671-CB2FD3403B18Q33829465-2C95CACF-EE60-4658-9761-2210E2422225Q33859439-CE36728E-5464-4F7C-8A99-CA8098EF150FQ33924619-6C93B920-0411-4BF1-A7BD-F4B0D1D4DEFDQ33991599-C7BFAF5F-8D2F-4E4C-BC6A-8279AD0ECE7DQ33995723-ECF3223E-F00F-46D4-A022-0C64ACEABE96Q34028816-70B0C6BD-0E7C-41AE-AB93-723DAFC88273Q34143522-99033F9F-4786-427B-95FA-A22F82E62A83Q34173505-F053AAC3-6F0A-45E9-A944-550A2A4EB990Q34186021-11773B2E-4FC4-49AA-A7FD-5D716BA3759CQ34295621-6939C006-91D4-482B-AA39-A38EF6584E03Q34296481-02E6434C-66CB-4136-A505-DFE0CFC1FEA2Q34325808-35F9862B-9B1B-442A-9508-5ADFF179E3FBQ34340552-93B98BF3-AEF9-40B9-A1D0-05FAA8AE65C8Q34512645-741E09D7-8252-47B9-B8BF-B5EFC6D02062Q34712612-039D7102-5FA9-4544-9724-3EB0F83C6C16Q34712645-02E20D0B-9DEB-4F83-85BA-9E09AF8BC5D1Q34924229-156E73D3-1E8B-48AF-A8CF-5151DB9498F8Q35037258-00E3A71E-76F6-43E4-B52F-19624B6F6862Q35154337-82C5FA83-3047-4707-B479-81AA55162E80Q35176048-22D29E52-B30F-44D7-AE04-27414752B640Q35208873-DE4A3112-F9FF-4079-A538-4BFFE88DD3FFQ35939806-FC6E364B-95D8-40D6-95BB-24F398C9EFCBQ35985157-4196387A-E423-44FD-82D7-3D90BBD1BC05Q36016557-A9F3BCDE-C00C-4CB6-9DAE-723581319873Q36074972-10B31D59-B18D-41A1-9DEB-BB45DC24090CQ36182415-0A88FCC1-AFCD-4C1C-B381-50B0EED70DE2Q36230522-D520C70B-72F0-43A5-AD97-53AB49D077A9Q36545237-9F179FE3-7EF2-4CE9-834A-DCFCC0BE7A1FQ36781251-1F3028F2-2166-448D-8FFE-2F2DBC298502Q36799733-410886C6-99CF-4A54-A372-243BC4340A82Q36864403-A9BAB2D1-813A-4273-817D-B1F551D84AE5Q36887350-12F93B26-305C-45DC-9D29-E818552E8304Q36985133-A3FC237C-5B49-4789-A582-BB02AB7871E8
P2860
Direct repression of cyclin D1 by SIP1 attenuates cell cycle progression in cells undergoing an epithelial mesenchymal transition.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Direct repression of cyclin D1 ...... helial mesenchymal transition.
@en
type
label
Direct repression of cyclin D1 ...... helial mesenchymal transition.
@en
prefLabel
Direct repression of cyclin D1 ...... helial mesenchymal transition.
@en
P2093
P2860
P356
P1476
Direct repression of cyclin D1 ...... thelial mesenchymal transition
@en
P2093
Cindy Vandewalle
Eugene Tulchinsky
J Kilian Mellon
Jakob Mejlvang
Marina Kriajevska
Tatyana Chernova
P2860
P304
P356
10.1091/MBC.E07-05-0406
P577
2007-09-12T00:00:00Z